TechFlow news, June 23 — According to an official announcement, Eyenovia, Inc. (Nasdaq: EYEN) today announced the completion of its previously disclosed $50 million private placement and successfully acquired 1,040,584.5 HYPE tokens at an average price of approximately $34, becoming the first Nasdaq-listed company to operate a validator node on the Hyperliquid blockchain.
CEO Michael Rowe stated that this financing marks the first step in executing the company's cryptocurrency reserve strategy, while it continues to focus on completing FDA registration development for the Optejet User-Fill Device (UFD), with registration expected to be submitted by September 2025.
Chief Investment Officer Hyunsu Jung said the successful acquisition of initial HYPE tokens paves the way for deeper participation in the Hyperliquid ecosystem.
Eyenovia plans to change its name to "Hyperion DeFi" and its stock ticker to "HYPD" upon board approval, continuing to advance ophthalmic technology innovation while providing shareholders access to a high-growth blockchain ecosystem.
